Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication
Juliane Lippert(University of Würzburg), Cristina L. Ronchi(University of Birmingham)
Cited by 119
Related Papers
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
|The Lancet Diabetes & Endocrinology|2020|247
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study
|The Lancet Diabetes & Endocrinology|2022|180
Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
|The Journal of Clinical Endocrinology & Metabolism|2017|90
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma
|Cancer Communications|2025|6